Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Water is a solvent and diluent for parenteral administration; it provides hydration and maintains osmotic balance. It has no pharmacological activity.
Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.
As a diluent for reconstitution of medications,As a vehicle for intravenous administration of compatible drug additives,For hydration in patients requiring fluid replacement
Intravenous replacement of intravascular volume and electrolytes in patients with normal or slightly acidic p H,Maintenance of fluid and electrolyte balance during surgery or in critical care,Correction of hypovolemia when isotonic fluid administration is appropriate
Intravenous administration; dose determined by clinical requirements for hydration, drug dilution, or vehicle for parenteral medications. Typical adult maintenance: 30 m L/kg/day, adjusted for electrolyte and fluid status.
Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.
Approximately 30-45 minutes; rapid redistribution due to constant renal clearance; clinically, water half-life is not typically measured since it is a vehicle
Not applicable; components follow first-order kinetics with rapid redistribution. Lactate half-life ~15-30 minutes (hepatic metabolism).
Water is not metabolized; it is distributed throughout body fluids and excreted primarily by the kidneys.
Acetate is metabolized primarily in the liver and muscles to bicarbonate.
Renal: >99% as free water; biliary/fecal: negligible
Primarily renal; >95% of infused ions (sodium, chloride, lactate, calcium, magnesium) are excreted unchanged in urine. Biliary/fecal elimination negligible (<1%).
0% (water does not bind to plasma proteins)
Negligible (<1%); ions are free in plasma (no significant protein binding).
0.55-0.7 L/kg (total body water); clinically, water distributes throughout total body water
0.4 L/kg; distributes mainly in extracellular fluid (ECF).
Intravenous: 100%; subcutaneous: ~100% (complete absorption); intramuscular: ~100%
100% (intravenous); not absorbed orally.
No specific GFR-based dose adjustment; monitor fluid balance and avoid fluid overload in renal impairment. In oliguric or anuric patients (GFR <10 m L/min), reduce volume to match insensible losses plus urine output.
Contraindicated in oliguric or anuric renal failure; in GFR <30 m L/min, avoid use or monitor electrolytes closely; no specific GFR-based dose adjustment.
No specific Child-Pugh based modification; use with caution in ascites or edema due to risk of fluid overload.
No specific Child-Pugh based adjustments; use with caution in hepatic impairment due to risk of fluid overload.
Weight-based: Neonates and infants: 60-100 m L/kg/day for maintenance; adjust for dehydration or ongoing losses. Administer via intravenous route.
Weight-based dosing: 5-10 m L/kg intravenous infusion over 1-2 hours, not to exceed 30 m L/kg/day.
Use lower end of dosing range due to decreased renal function and comorbidities; monitor for fluid overload and electrolyte disturbances. Typical starting dose: 20-30 m L/kg/day intravenously.
Use with caution due to increased risk of fluid overload and electrolyte imbalance; adjust rate and volume based on renal function and comorbidities, typical initial dose 500 m L over 2-3 hours.
None.
None.
Use only if solution is clear and container is intact,Do not use for intravenous injections that require isotonic solutions unless additives are used to achieve isotonicity,Risk of hemolysis if administered as a large volume hypotonic solution,Monitor for fluid overload in patients with renal impairment or cardiac disease
Use with caution in patients with severe renal impairment, heart failure, or conditions associated with sodium retention,Monitor serum electrolytes, fluid balance, and acid-base status during prolonged administration,Risk of volume overload in patients with compromised cardiac or renal function,Contains aluminum; may be toxic with prolonged use in patients with renal impairment
Known hypersensitivity to any component,Use as a large volume intravenous infusion without appropriate additives to achieve isotonicity
Hypersensitivity to any component,Severe hypernatremia or severe hyperchloremia,Severe metabolic alkalosis,Patients with contraindications to intravenous fluid administration
No known food interactions. Patients on a sodium-restricted diet should be aware that this product contains no sodium.
No food interactions are relevant as Physiosol p H 7.4 is not ingested. It is used exclusively for topical irrigation during medical procedures.
Sterile Water for Injection is a parenteral fluid devoid of pharmacologic activity. There is no known teratogenic risk across all trimesters; water is an essential nutrient with no expected fetal harm when administered appropriately.
Physiosol p H 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a physiological solution. However, large volumes or rapid administration could theoretically cause maternal electrolyte imbalances, which may indirectly affect the fetus.
Compatible with breastfeeding; water distributes into breast milk without known adverse effects. No M/P ratio applicable as it is a non-medicinal vehicle.
Physiosol p H 7.4 is compatible with breastfeeding. No M/P ratio is available; however, components are normal plasma constituents and unlikely to be excreted into breast milk in clinically significant amounts.
No dose adjustment needed; water clearance and distribution remain unchanged in pregnancy.
No specific dose adjustment is required for pregnancy. However, consider increased plasma volume and glomerular filtration rate in pregnancy; standard dosing is appropriate, but monitor for volume overload.
Sterile water for injection is not intended for direct intravenous administration; it is used for reconstitution of medications or as a diluent. If given intravenously without proper tonicity adjustments, it can cause hemolysis, hyponatremia, and cerebral edema.
Physiosol p H 7.4 is a balanced crystalloid solution used for irrigation, not for systemic administration. In the operating room, it is preferred for peritoneal lavage due to its neutral p H, which minimizes tissue irritation. Do not use for intravenous infusion; verify labeling to avoid confusion with IV solutions. Warm to body temperature before use to prevent hypothermia during large-volume irrigation.
This product is used to mix with other medications before they are given as an injection or infusion.,Do not inject this water directly into a vein as it can cause serious side effects.,Tell your healthcare provider if you have any allergies or if you are on a sodium-restricted diet.
This solution is used to rinse body cavities during surgery, not for intravenous use.,You may feel a cooling sensation during irrigation; this is normal.,Report any signs of infection at the surgical site, such as redness, swelling, or discharge.,Do not attempt to use this solution at home; it is for hospital use only.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about STERILE WATER FOR INJECTION IN PLASTIC CONTAINER vs PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER, answered by our medical review team.
STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is a Irrigation Solution that works by Water is a solvent and diluent for parenteral administration; it provides hydration and maintains osmotic balance. It has no pharmacological activity.. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is a Irrigation Solution that works by Replacement of extracellular fluid and electrolytes; provides buffering capacity via bicarbonate precursor (acetate) and maintains physiological p H.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between STERILE WATER FOR INJECTION IN PLASTIC CONTAINER and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is: Intravenous administration; dose determined by clinical requirements for hydration, drug dilution, or vehicle for parenteral medications. Typical adult maintenance: 30 m L/kg/day, adjusted for electrolyte and fluid status.. The standard adult dose of PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is: Intravenous infusion, rate adjusted based on clinical status and electrolyte needs; typical adult dose is 500-1000 m L over 1-2 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between STERILE WATER FOR INJECTION IN PLASTIC CONTAINER and PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. STERILE WATER FOR INJECTION IN PLASTIC CONTAINER is classified as Category C. Sterile Water for Injection is a parenteral fluid devoid of pharmacologic activity. There is no known teratogenic risk across all trimesters; water is an essential nutrient with no. PHYSIOSOL PH 7.4 IN PLASTIC CONTAINER is classified as Category C. Physiosol pH 7.4 (balanced electrolyte solution) is considered low risk for teratogenicity. There are no known fetal risks associated with its use in any trimester, as it is a phys. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.